LaLonde ex rel. M.L. v. Secretary of Health & Human Services

746 F.3d 1334, 2014 WL 1258137, 2014 U.S. App. LEXIS 5720
CourtCourt of Appeals for the Federal Circuit
DecidedMarch 28, 2014
DocketNo. 2013-5088
StatusPublished
Cited by465 cases

This text of 746 F.3d 1334 (LaLonde ex rel. M.L. v. Secretary of Health & Human Services) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
LaLonde ex rel. M.L. v. Secretary of Health & Human Services, 746 F.3d 1334, 2014 WL 1258137, 2014 U.S. App. LEXIS 5720 (Fed. Cir. 2014).

Opinions

Opinion for the court filed by Circuit Judge PROST. Dissenting opinion filed by Circuit Judge NEWMAN.

PROST, Circuit Judge.

This case, brought under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-l to -34, as amended (the “Vaccine Act”), presents the question whether petitioner Cynthia LaLonde, on behalf of her son M.L., has proven by a preponderance of the evidence that M.L.’s diphtheria-tetanus-acellular pertussis (“DTaP”) vaccination caused a focal brain injury. The special master found that although M.L.’s DTaP vaccination likely caused his initial anaphylactic reaction, Ms. LaLonde failed to establish under any reliable medical theory that M.L.’s ana-phylaxis caused a focal brain injury. See La Londe v. Sec’y of Health & Human Servs., No. 06-435V, 2012 WL 5351164 (Fed.Cl.Spec.Mstr. Sept. 28, 2012). After a careful consideration of the record, the U.S. Court of Federal Claims upheld that finding. See La Londe v. Sec’y of Health & Human Servs., 110 Fed.Cl. 184 (2013). We affirm.

[1337]*1337I. Background

The relevant facts are primarily those found by the special master in his detailed September 28, 2012 decision. See La Londe, 2012 WL 5351164, at *3-6. M.L. was born on September 24, 2003. At his fifteen-month wellchild visit, his pediatrician noted that M.L. was walking and generally developing normally but did not “want to talk.” On April 14, 2005, M.L. received several immunizations, including the DTaP vaccination. About five hours later, M.L. allegedly began experiencing an abnormally high fever and some swelling. The next day M.L. was admitted to the hospital with a diagnosis of “vaccine adverse reaction with secondary fever, an-giodema, and anaphylactoid reaction.” J.A. 20. He was discharged on April 16, 2005. However, the following morning M.L.’s mother called an ambulance because M.L. was exhibiting signs of hypothermia and seizure-like episodes.

In the weeks and months following the administration of the DTaP vaccination, M.L.’s vocabulary allegedly decreased, worrying his parents and his doctors. An MRI of M.L.’s brain with and without contrast was normal, revealing a deep bilateral middle ear infection but no brain damage. Nonetheless, M.L. continued to exhibit several “seizure-like” activities, but after a few months he was weaned off anti-epileptic medication. After observing M.L.’s developmental delays and repetitive behaviors, a pediatric neurologist placed M.L. in the autism spectrum disorder category.

II. PROCEDURAL HISTORY

Ms. LaLonde filed a petition under the Vaccine Act on June 1, 2006, seeking compensation for M.L.’s alleged injuries. The case was assigned to a special master, who heard expert testimony from Dr. Marcel Kinsbourne for Ms. LaLonde. Dr. Kinsb-ourne testified that M.L. experienced a two-phase anaphylactic reaction that included a delayed second state. He pointed to medical literature that supports the existence of late-phase anaphylactic reactions and offered three possible mechanisms of injury that have been shown in medical literature to result from an anaphylactic reaction. However, Dr. Kinsbourne was unable to point to anywhere in the literature that describes the sequence of events that are presented in this case. Dr. Kinsbourne also admitted that he lacked any reliable medical evidence supporting the notion that anaphylactic shock can cause focal brain injuries.

After reviewing the evidence in the case, the special master saw what he called a “major gap” in Ms. LaLonde’s case. La Londe, 2012 WL 5351164, at *1. He alerted Ms. LaLonde to this fact and allowed her to submit new evidence, updated medical records, and a revised expert report. Id. at *2. Nonetheless, after re-reviewing the entire record, the special master found two decisive defects in Ms. LaLonde’s case: (1) Dr. Kinsbourne’s opinions were based on information provided by Ms. LaLonde and not on medical information found in the record; and (2) the record indicated — and all experts agreed — that M.L.’s initial reaction to the immunizations resolved, and Dr. Kinsbourne’s theory that there was a secondary, delayed anaphylactic reaction was unsupported by the record. Id. at *3.

On review, the Court of Federal Claims concluded that the special master abused his discretion by discrediting Dr. Kinsb-ourne’s opinions that were based on statements made by Ms. LaLonde, even if some of her statements were in conflict with the medical records. La Londe, 110 Fed.Cl. at 204. Nonetheless, the Court of Federal Claims concluded that this abuse of discretion was “harmless.” Id. It explained that the special master “quite properly re[1338]*1338quired [Ms. LaLonde] to carry her burden to bring forward a reliable medical or scientific explanation,” and she failed to do so. Id. at 201. Her expert, Dr. Kinsb-ourne, testified that he had never seen an anaphylactic reaction lead to a focal brain injury, he did not find any support for a link in the medical literature, and he had an incomplete understanding of how the reaction could evolve into a focal brain injury. Id.

We have jurisdiction to review the final judgment of the Court of Federal Claims under 42 U.S.C. § 300aa-12(f).

III. The Vaocine Act

In 1986, Congress passed the Vaccine Act to establish a program administered by the Secretary of Health and Human Services to increase the safety and availability of vaccines. See 42 U.S.C. § 300aa-l; Terran v. Sec’y of Health & Human Servs., 195 F.3d 1302, 1307 (Fed.Cir.1999). The Vaccine Act created the National Vaccine Injury Compensation Program, through which claimants could petition to receive compensation for vaccine-related injuries or death. See 42 U.S.C. § 300aa-10(a).

To receive compensation, a claimant must show, by a preponderance of the evidence, that the vaccinated person received a covered vaccine and either: (1) suffered an injury, condition, or a significant aggravation of a preexisting injury or condition listed on the Table within the requisite time frame, in which case causation is presumed (a “Table injury”); or (2) suffered an injury or condition or suffered the significant aggravation of a pre-exist-ing injury or condition not on the Table, in which case causation must be proven (a “non-Table injury”). See 42 U.S.C. §§ 300aa-ll(c)(l)(C), 300aa-14; 42 C.F.R. § 100.3 (2011). To prove actual causation in a non-Table injury case, the petitioner must

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
746 F.3d 1334, 2014 WL 1258137, 2014 U.S. App. LEXIS 5720, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lalonde-ex-rel-ml-v-secretary-of-health-human-services-cafc-2014.